A wholly owned subsidiaryof Eli Lilly and Company
Explore our science.
You are not alone in the battle against cancer.
Learn about the next generation in precision oncology.
Learn more about our clinical trials and how you can contribute to the future of cancer care.
Located in Toronto, Canada, PIRI is POINT’s state of the art GMP R&D center, focused on bringing novel programs from discovery to the clinic.
Enables on-site research and development with a wide variety of imaging and therapeutic isotopes.
GE PETtraceTM 800 cyclotron and hot cells enable on-site production of many medical isotopes.
PIRI is located in Toronto General Hospital, which is part of the largest health research organization in Canada, the University Hospital Network (UHN), facilitating rapid translation into the clinic.